Skip to main content
Clinical Trials/CTRI/2024/07/070444
CTRI/2024/07/070444
Not Yet Recruiting
Phase 3

An interventional study to evaluate the efficacy and safety of topical metformin in the treatment of melasma at a tertiary care center - NI

Anu Sarah Philip0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Anu Sarah Philip
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Anu Sarah Philip

Eligibility Criteria

Inclusion Criteria

  • ADULT MALES OR FEMALES WITH A CLINICAL DIAGNOSIS OF MELASMA

Exclusion Criteria

  • Age less than 18 years or more than 80 years.
  • Patients with a history of photosensitivity disorders.
  • Patients on medications known to cause hyperpigmentation or photosensitivity.
  • Patients on immunosuppressants .
  • Patients with facial pigmentation caused by conditions other than melasma.

Outcomes

Primary Outcomes

Not specified

Similar Trials